Please assess the completion status of the following clinical trial:

Trial Title: Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women at least 36 weeks gestation requiring cervical ripening and induction of labor~Exclusion Criteria:~* No uterine scar (no previous delivery by cesarean section)~* No multiple gestation~* No condition that disallows use of prostaglandins for induction of labor~* No more than 3 previous vaginal births beyond 24 weeks gestation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MVI 100 (Type: EXPERIMENTAL): Misoprostol vaginal insert 100 mcg over 24h
- MVI 50 (Type: EXPERIMENTAL): Misoprostol vaginal insert 50 mcg over 24h
- Cervidil 10 mg vaginal insert (Type: ACTIVE_COMPARATOR): Cervidil 10 mg over 24h

Based on this trial design, predict the completion outcome and termination type (if applicable).